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Background: The long-term effects of mobile health (mHealth) interventions have not been documented, especially in
resource-constrained settings.
Objective: This study aimed to assess the effects of a 1-year mHealth intervention on blood pressure levels and body weight
in low-resource urban settings in Peru, 4 years after the completion of the original study.
Methods: Four years after the original Grupo de Investigación en Salud Móvil en America Latina (GISMAL) study, we attempted
to contact the 212 individuals originally enrolled in the study in Peru. The primary outcomes were systolic and diastolic blood
pressure levels and hypertension incidence. Secondary outcome measures were body weight, BMI, and self-reported target
behaviors. The study personnel collecting the data were masked to the group assignment. Linear mixed models were used to
evaluate the effects of the intervention on primary and secondary outcomes in an intention-to-treat analysis.
Results: Data from 164 (77.4%) of the 212 originally enrolled participants were available and analyzed (80 in the intervention
group and 84 in the control group). The intervention did not result in changes in systolic (–2.54 mm Hg, 95% CI –8.23 to 3.15)
or diastolic (3.41 mm Hg, 95% CI –0.75 to 7.57) blood pressure compared with the control group. The intervention reduced the
risk of developing hypertension, but the result was not significant (risk ratio (RR) 0.76, 95% CI 0.45-1.28). However, those who
received the intervention had lower body weight (–5.42 kg, 95% CI –10.4 to –0.48) and BMI (–2.56 kg/m2, 95% CI –4.46 to
–0.66). In addition, compared to the control participants, those who received ≥50% of the scheduled calls during the intervention
had greater reductions in body weight (–6.23 kg, 95% CI –11.47 to –0.99) and BMI (–2.81 kg/m2, 95% CI –4.77 to –0.85).
Conclusions: An mHealth intervention comprising motivational interview calls and SMS text messaging appears to have effects
on health 4 years after intervention completion. Although there were no effects on blood pressure levels, important reductions in
body weight and BMI were seen 5 years after randomization. Thus, mHealth appears to be a promising preventive strategy for
noncommunicable diseases in resource-constrained settings.
Trial Registration: Clinicaltrials.gov NCT01295216; https://clinicaltrials.gov/ct2/show/NCT01295216
(J Med Internet Res 2020;22(4):e14595) doi: 10.2196/14595
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Hypertension is the most important risk factor for stroke and
premature cardiovascular disease (CVD) [1,2]. Prehypertension
is defined as a systolic blood pressure (SBP) of 120-139 mm
Hg or a diastolic blood pressure (DBP) of 80-89 mm Hg [3];
however, the risks of coronary artery disease and stroke rise
progressively as blood pressure increases above 115/75 mm Hg
[4]. As a result, interventions focused on individuals with
prehypertension may be of interest to address the burden of
hypertension.
Worldwide, the number of individuals who own a mobile phone
is increasing. Mobile health (mHealth), an ever-expanding
concept, uses this growing technology in a wide range of health
care applications [5]. Interventions using mHealth have the
potential to shorten gaps to reach underserved populations [6],
providing a more flexible platform for improving patient
self-care. mHealth technology has been applied successfully to
meet the treatment of infectious chronic diseases such as
tuberculosis (treatment adherence, prevention, and education)
[7] and HIV/AIDS (uptake of sexual health services and
information) [8], and some mHealth interventions have been
used to promote changes toward healthier lifestyles, thereby
improving health outcomes [9-11]. However, the number of
studies assessing the impact of mHealth on specific
cardiovascular outcomes is more limited in low-income and
middle-income settings [6,12], and although the success of these
interventions is evident, the long-term impact of interventions
involving mHealth technology is not.
Some interventions have been proved to be effective to change
lifestyle behaviors. A systematic review found that interventions
based on the Transtheoretical Model can reduce fat consumption,
increase the consumption of fruit and vegetables, and increase
physical activity depending upon the progression through the
stages of change [13]. Similarly, a recent systematic review
reported that telephone-based interventions that
incorporate motivational interviewing are promising for weight
loss [14]. The GISMAL (Grupo de Investigación en Salud Móvil
en America Latina, in Spanish) study was a 1-year randomized
controlled trial conducted in three Latin American countries
(Argentina, Guatemala, and Peru) using the Transtheoretical
Model and motivational interviewing.
The aim of the GISMAL study was to assess whether an
mHealth intervention would improve the cardiometabolic profile
(ie, reduce blood pressure levels and body weight) among
individuals with prehypertension [15,16]. Although the
intervention did not reduce blood pressure levels, it was
associated with a reduction of body weight and improvement
in some dietary habits, especially in Peru. One year may not be
a sufficient period to observe changes in blood pressure levels
due to a behavioral intervention or to assess whether the effects
of the intervention can continue to provide benefit after it is
stopped; therefore, we aimed to evaluate the long-term effects
(ie, 4 years after completion of the original study) of the
GISMAL mHealth intervention on blood pressure and body
weight in participants recruited in Peru.
Methods
Original Intervention and Settings
The GISMAL study (NCT01295216) was performed in 2012.
It was a multicenter, parallel-group, randomized controlled trial
that was stratified by sex and age (30-44 years and 45-60 years).
Details about the intervention have been published elsewhere
[15]. In brief, randomization was stratified by country using
minimization by sex and age group. The intervention lasted 12
months, followed a standardized protocol, which was
implemented by trained nutritionists and comprised monthly
phone calls in which the nutritionists used motivational
interview techniques. Participants were contacted through their
personal mobile phones, and the conversations focused on
reduction of dietary sodium intake, reduction of high-fat and
high-sugar food intake, increase in fruit and vegetable
consumption, and promotion of physical activity. In addition,
SMS text messages were sent weekly to participants to reinforce
the calls [17]. The same nutritionist entered the information
obtained during each call into a web-based platform to customize
the weekly text messages delivered to participants in the
following month. Several text messages were developed and
culturally adapted to each country to guarantee understanding,
adequacy of the message wording, and tone, as previously
described [18].
Eligibility criteria included men and women aged 30-60 years
who owned mobile phones and with SBP and DBP in the
prehypertension range (between 120 and 139 mm Hg and
between 80 and 89 mm Hg, respectively). People with an earlier
diagnosis of diabetes or hypertension, illiterate individuals, and
pregnant women were excluded.
The total sample of the original intervention was 636 people
from Argentina, Guatemala, and Peru; however, the sample size
of the trial was calculated separately for each country. Thus,
researchers from Peru enrolled 212 individuals to ensure a
change in systolic blood pressure levels of 5 mm Hg. Subjects
from two different sites (Pampas de San Juan de Miraflores and
Hospital Nacional Cayetano Heredia) were recruited; 107 were
allocated to the intervention group and 105, to the control group.
The outcomes of interest were blood pressure, body weight,
diet quality, and physical activity; these were evaluated at
baseline (randomization) and at 6 and 12 months later.
Follow-up Assessment
Between August and December 2017, on average, 5 years after
randomization (ie, 4 years after completion of the intervention),
participants enrolled in Peruvian sites were contacted to
determine the long-term effects of the intervention (ie, whether
the effects of the mHealth intervention were maintained over
time and affected blood pressure levels as originally planned).
In the time between the 1-year and 5-year assessments, the
research team had no contact with the participants. As per the
original study [15], where participants had moved or had
changed their telephone number, family members or friends
reported as next of kin in the original study were contacted to
find the participants.
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Primary and Secondary Outcomes
As in the original study, in this new assessment, the primary
outcomes were SBP and DBP, both measured in millimeters of
mercury; in addition, hypertension incidence was included as
a primary outcome. The secondary outcomes were the same as
in the original study, including body weight (in kilograms),
BMI (kg/square meter), physical activity (in metabolic
equivalents [METs] per minute of a task per week), and diet
patterns (daily intake of fruits and vegetables, high-sodium food,
and of high-fat and high-sugar foods).
SBP and DBP were measured using an automatic monitor
(HEM-742 INT, Omron) as in the original study. Measurements
were taken in triplicate; after a 5-minute resting period, the first
blood pressure measurement was taken, and the time between
subsequent measurements was at least 1 minute. The average
of the second and third blood pressure measurements was used
for the analyses. All measurements were taken with the
participant in a seated position using the same arm where the
original measurement was taken.
Body weight was measured three times, following standardized
techniques. We used the same digital scales (Seca 803/Omron
SC-100) used in the original study and calibrated them to an
accuracy of 100 g. BMI was calculated by dividing weight (kg)
by height (m) squared. Primary and secondary outcomes were
evaluated as numerical variables; however, hypertension
incidence was evaluated by taking into account the new cases
of hypertension detected since randomization.
Changes in physical activity were evaluated using the METs
obtained from the short version of the International Physical
Activity Questionnaire [19]. Moreover, diet patterns were
evaluated using the same food frequency questionnaire used in
the original study; the questions focused on the consumption
of foods with high contents of sodium, simple sugars, trans fats,
and saturated fats, as well as on the consumption of fruits and
vegetables [20].
Other important variables were considered, including
sociodemographic data (age, sex, marital status, household
income, years of education, employment status, and health
insurance coverage) as well as self-reported lifestyle behaviors
(smoking status, alcohol intake, physical activity, and daily
dietary intake). In addition, stages of change (precontemplation,
contemplation, preparation, action, and maintenance) according
to the Transtheoretical Model [21] were described (physical
activity, intake of servings of 5 fruits and vegetables, food with
harmful fats, high-sugar food and beverages, high-sodium
processed foods, salt added at the table, and salt added for
cooking).
Statistical Analysis
Data were analyzed using STATA 13 software (Stata Corp).
The intention-to-treat principle was used to compare the
intervention and control arms. Means and standard deviations
for numerical continuous variables and proportions and
frequencies for categorical variables were used to describe the
study population enrolled in Peru at baseline.
For the incidence analysis, we excluded patients whose
hypertension status could not be confirmed, including those
who were lost to follow-up and who had died. Person-years of
follow-up were calculated by summing the follow-up times for
the remaining participants. For participants with a new diagnosis
of hypertension, only half of the time between the last
assessment and the previous assessment was used in this sum
since the actual date of diagnosis was unknown. Incidence rates
and their 95% confidence intervals were then estimated. Poisson
regression models with log link functions and robust standard
errors to account for cluster effects were calculated by reporting
the risk ratio (RR) and 95% confidence intervals.
Differences in primary and secondary outcomes were assessed
using linear mixed models, including two levels (assessments
as level 1 units and subjects as level 2 clusters). As in the
original study, the a priori defined model included the interaction
between the intervention and the time of follow-up as categorical
variables (baseline, 6 months, 12 months, and 5 years), adjusting
by sex and age to reverse the stratification during randomization.
The regression model results focus on the 5-year assessment
and are presented as coefficients with their respective 95% CI.
A dose-response analysis was also conducted using appropriate
statistical techniques but was categorized in two groups instead
of the three groups in the original study: participants who
received <6 (50%) and ≥6 (50%) of the scheduled motivational
interviewing calls.
Ethical Aspects
As we only contacted participants from the Peruvian sites, this
new assessment was approved by the Ethics Committee of the
Universidad Peruana Cayetano Heredia, Lima, Peru. To ensure
the autonomy of the participants, written informed consent was
obtained before we assessed the participants. The data collected
were kept confidential and accessed only by the researchers
who performed the study.
Results
Principal Findings
In Peru, a total of 1495 participants were assessed for eligibility;
finally, 212 were randomly assigned to the intervention or
control arm. After the first year of the study, 193 participants
were retained in the study (n=95, 49.2% in the intervention
group and n=98, 50.8% in the control group); 5 years after
randomization, 1 (0.5%) participant had died, and 47 (22.2%)
were lost to follow-up. Therefore, data from 164 individuals
were analyzed (n=80, 48.8% in the intervention group and n=84,
51.2% in the control group; Figure 1).
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Figure 1. Trial profile in Peru.
According to the baseline comparison, the randomization works
relatively well, as the distributions of the characteristics of the
study population were similar in the intervention and control
groups (Multimedia Appendix 1).
Primary and Secondary Outcomes
In intention-to-treat analysis, the intervention did not result in
changes in SBP (–2.54 mm Hg, 95% CI –8.23 to 3.15) or DBP
(3.41 mm Hg, 95% CI –0.75 to 7.57) compared to controls.
Among secondary outcomes, those who received the
intervention had lower body weight (–5.42 kg, 95% CI –10.4
to –0.48) and BMI (–2.56 kg/m2, 95% CI: –4.46 to –0.66)
compared to the control group. However, there was no evidence
of effects of the intervention on physical activity levels, intake
of fruits and vegetables, or intake of high-sodium food, but there
were small increases in the intake of high-fat and high-sugar
foods (Table 1).
The intervention reduced the risk of developing hypertension
after 5 years of follow-up (RR 0.76, 95% CI 0.45-1.28);
however, the estimates were not significant (Table 2).
Table 1. Primary and secondary outcomes at 5 years of follow-up: results from mixed linear models.
P valueMean differenceb β (95% CI)Control group (n=84)Intervention group (n=80)Outcome
Primary
.38–2.54 (–8.23 to 3.15)126.6 (12.5)124.0 (12.1)Systolic blood pressure
.113.41 (–0.75 to 7.57)74.2 (9.0)74.4 (8.8)Diastolic blood pressure
Secondary
.03–5.42 (–10.4 to –0.48)79.8 (15.7)78.0 (15.1)Body weight (kg)
.008–2.56 (–4.46 to –0.66)32.8 (5.9)31.4 (5.2)BMI (kg/m2)
.86–61.12 (–745.94 to 623.70)911 (1274.6)1077 (1641.6)Physical activity (METsa/min per week)
.860.05 (–0.47 to 0.56)1.65 (0.94)1.62 (0.95)Daily intake of fruits and vegetablesb
.20–0.22 (–0.55 to 0.11)0.82 (0.69)0.56 (0.60)Daily intake of high-sodium foodb
.020.98 (0.14 to 1.82)3.93 (1.73)3.72 (1.69)Daily intake of high-fat and high-sugar foodsb
aMETs: metabolic equivalents.
bMean differences were estimated using linear mixed models using information from the baseline and 6-month, 12-month, and 5-year follow-ups and
were controlled by sex and age.
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Table 2. Incidence of hypertension by intervention group and dose-response to intervention 5 years after randomization.
P valueRegression modela RR (95% CI)New cases of hypertension during follow-up
Yes (n=50)No (n=142)
Intention-to-treat analysis
—1 (Reference)29 (29.6%)69 (70.4%)Control
.300.76 (0.45-1.28)21 (22.3%)73 (77.7%)Intervention
Dose-response analysis
—1 (Reference)29 (29.6%)69 (70.4%)Control
.441.33 (0.64-2.75)10 (33.3%)20 (66.7%)<50% (<6 calls)
.070.55 (0.29-1.04)11 (17.2%)53 (82.8%)≥50% (≥6 calls)
aModels were adjusted by age and sex, as randomization was stratified for these variables.
Dose-Response Analysis
No changes in SBP (–4.05 mm Hg, 95% CI: –10.11 to 2.02) or
DBP (1.48 mm Hg, 95% CI: –2.84 to 5.79; Table 3) were
observed among participants receiving ≥50% of motivational
calls. On the other hand, those receiving ≥50% of scheduled
calls during the intervention had a 45% reduction (RR 0.55,
95% CI: 0.29-1.04) in the risk of developing hypertension 5
years after randomization; however, the estimates were not
significant (Table 2).
Among secondary outcomes, participants in the intervention
group who received ≥50% of calls had greater reductions in
body weight (–6.23 kg, 95% CI: –11.47 to –0.99) and BMI
(–2.81 kg/m2, 95% CI: -4.77; -0.85); however, there were no
changes in the other secondary outcomes (Table 3).
Table 3. Dose response to intervention in primary and secondary outcomes at 5-year follow-up.
Mean difference (≥50%/≥6 calls)b (n=54)Mean difference (<50%/<6 calls)b (n=26)
P valueβ (95% CI)P valueβ (95% CI)
Primary outcomes
.19–4.05 (–10.11 to 2.02).900.42 (–5.89 to 6.72)Systolic blood pressure
.501.48 (–2.84 to 5.79).0047.13 (2.31 to 11.95)Diastolic blood pressure
Secondary outcomes
.02–6.23 (–11.47 to –0.99).31–3.57 (–10.47 to 3.34)Body weight (kg)
.005–2.81 (-4.77; -0.85).19–1.79 (–4.45 to 0.87)BMI (kg/m2)
.8859.37 (–703.91 to 822.64).67–163.55 (–915.48 to 588.38)Physical activity (METsa/min per week)
.89–0.04 (–0.56; 0.49).450.25 (–0.39 to 0.89)Daily intake of fruits and vegetablesb
.11–0.28 (–0.62; 0.06).82–0.05 (–0.47 to 0.37)Daily intake of high-sodium foodb
.140.64 (–0.20; 1.49).0021.74 (0.65 to 2.83)Daily intake of high-fat and high-sugar foodsb
aMETs: metabolic equivalents.
bMean differences were estimated using linear mixed models using information from the baseline, 6-month, 12-month, and 5-year follow-ups and were
controlled by sex and age.
Discussion
Main Findings
Although no significant changes were observed in blood
pressure levels 4 years after the original intervention was
completed, our findings demonstrate important reductions in
body weight and BMI. Moreover, participants who received
≥50% of motivational calls during the 1-year intervention
potentially benefited most because greater reductions of body
weight and BMI were observed; this may have further impact
on hypertension incidence, as suggested by the risk estimates.
Notably, none of the changes found in the behavioral factors
could explain the reductions in body weight and BMI.
Comparison With Previous Studies
To our knowledge, this is one of the first randomized controlled
trials assessing the long-term effects of an mHealth intervention
created to promote healthy lifestyle behaviors among subjects
at high risk of CVD (ie, with prehypertension) in Latin America.
Two relatively recent systematic reviews highlighted the limited
number of mHealth interventions in resource-constrained
settings, especially from the prevention perspective [6,12].
J Med Internet Res 2020 | vol. 22 | iss. 4 | e14595 | p. 5http://www.jmir.org/2020/4/e14595/
(page number not for citation purposes)
Bernabe-Ortiz et alJOURNAL OF MEDICAL INTERNET RESEARCH
XSL•FO
RenderX
Among existing studies, Green et al [22] demonstrated that
web-delivered pharmacy team care resulted in greater reduction
in SBP and improved blood pressure 6-18 months after
completion of the interventions. Similarly, Margolis et al [23]
showed that intensive intervention based on blood pressure
telemonitoring with pharmacist management had sustained
effects for up to 24 months (12 months after the intervention
ended). Therefore, our study expands on current data by
suggesting that mHealth intervention has a sustained effect on
body weight 4 years after the intervention ended. On the other
hand, Appel et al [24] reported a reduction of 4.6 kg among
obese individuals receiving remote support (ie, telephone,
website, and email) compared to a control group after 24 months
of follow-up; however, no impact on CVD events or all-cause
mortality was observed. On the other hand, Rubinstein et al [15]
reported no change in blood pressure levels after 12 months of
intervention in prehypertensive individuals, but participants in
the intervention group had modest reductions in body weight
and BMI and reported lower intake of high-fat and high-sugar
foods. Recently, a meditation smartphone app appeared to
decrease SBP in a 6-month dose-response feasibility trial;
however, the adherence to this intervention declined over time
[25].
The utility of mobile phone text messages has been reported
mainly to support hypertension treatment and management,
especially as reminders [26,27]. For example, Bobrow et al [26],
using SMS text messages with hypertensive individuals, reported
a small reduction in SBP compared to usual care after 12 months
of intervention. Similarly, Hacking et al [27] reported that text
messages only improved self-reported behavior changes.
However, limited literature has assessed the long-term impact
of mHealth interventions on the cardiometabolic profiles of
prehypertensive individuals.
The GISMAL intervention had a marked long-term impact on
body weight and BMI. Previous results of the original study at
the Peruvian site showed reductions of 1.24 kg in body weight
and 0.53 kg/m2 in BMI among those in the intervention arm
after 1 year of follow-up (Multimedia Appendix 2) [15]. These
new results show that 4 years after the completion of the original
study, both body weight and BMI are much lower among
individuals who received the intervention than in those who did
not. Thus, this 1-year intervention not only helped sustain
previous weight loss but also helped ensure a greater weight
reduction over time. Surprisingly, despite the clear reductions
in weight and BMI at long-term follow-up, there was weak
evidence of changes in blood pressure levels. The sample size
of the original trial was calculated to detect a difference of 5
mm Hg in each country, and some decreases in SBP and
hypertension incidence, especially among those receiving higher
doses of the intervention, were noted.
On the other hand, there were no differences among evaluated
behavioral factors. These findings suggest that the tools and
questionnaires used during the evaluation were not accurate
enough to assess selected lifestyles or that the intervention led
to changes in unmeasured behaviors that were maintained
beyond the period of the study intervention. Other studies have
reported similar impacts of mHealth on bodyweight and BMI,
but most of them were in the short term [28,29]. Therefore, our
results support the fact that a short mHealth intervention
comprising motivational interviewing calls and weekly text
messages helps participants retain healthy habits and may help
them maintain long-term effects.
Relevance to Public Health
Recently, the American Heart Association and the American
College of Cardiology included individuals with prehypertension
as having hypertension stage 1 (SBP=130-139 mm Hg or
DBP=80-89 mm Hg) and proposed that these individuals need
appropriate management [30]. However, although people with
prehypertension are at a high risk of developing CVD, they do
not receive treatment in resource-constrained settings. This
highlights the need for prevention strategies to avoid further
complications.
mHealth appears to be a promising way to reduce the risk of
these individuals because participants in our intervention group
only received monthly health counselling and weekly text
messages for 12 months. Regular communication between
patients and clinics or health posts may improve adherence to
healthy behaviors, which in turn can prevent the onset of CVD
later on and contribute to other positive health outcomes [31,32].
In addition, the effects of our intervention could have been
greater if booster appointments were utilized, thus extending
the behavior changes.
The perceived benefits of this mHealth intervention must
outweigh the effort of receiving calls and text messages because
self-management is an ongoing process that requires significant
iteration. The introduction of apps to support calls and text
messages even after the intervention period can help produce
sustainable outcomes. However, evidence has demonstrated
that in interventions based only on technology, when people
are left alone with mobile self-help apps, participants are less
adherent [33,34] and less motivated to engage in the proposed
program than participants who are accompanied by health staff
or coaches or who have other types of face-to-face interaction
as part of the intervention [35]. The reductions in mean body
weight and BMI indicate possible long-term success of the
intervention, with a possible impact on hypertension; hence,
this intervention can potentially be implemented to ensure
prevention of CVD.
Limitations
Some limitations must be highlighted. First, this study included
only data from participants in Peruvian settings, although the
original intervention was conducted in three countries
(Argentina, Guatemala, and Peru). However, the effects of the
intervention were especially important in Peru, as shown by the
12-month results [15], and the sample size of the trial was
calculated separately for each country. Second, the rate of
attrition was over 20% after 5 years; thus, some bias may arise
in the results. Despite this, the intention-to-treat principle was
used in all the analyses. Third, the original intervention was
based on the Transtheoretical Model, which is mainly used for
smoking cessation [36,37]. Although recent literature shows
the use of this model in other interventions [13], the intervention
was adapted to be applied for cardiovascular prevention in
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resource-constrained settings. Fourth, we did not assess
differential exposition to other preventive interventions since
study randomization. However, as the participants did not have
hypertension or any other noncommunicable condition, the
effects of this limitation may be negligible. Finally, recall and
desirability bias may be present at the moment of evaluation,
as is usual in these types of studies. However, validated scales
and standardized procedures were used to reduce these biases
as in the original study.
Conclusion
A 1-year mHealth intervention comprising motivational
interview calls and text messages appears to have long-term
effects on health 4 years after intervention completion. Although
we detected no effects on blood pressure levels, important
reductions of body weight and BMI were observed. Individuals
receiving ≥50% of calls had greater reductions in body weight
and BMI, and a potential effect on hypertension incidence was
observed. Thus, mHealth appears to be a promising preventive
strategy for noncommunicable diseases in resource-constrained
settings.
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